These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29675788)

  • 1. Recent advances in tuberculosis diagnostics in resource-limited settings.
    Seki M; Kim CK; Hayakawa S; Mitarai S
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1405-1410. PubMed ID: 29675788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The New Xpert MTB/RIF Ultra: Improving Detection of
    Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.
    Shah NS; Moodley P; Babaria P; Moodley S; Ramtahal M; Richardson J; Heysell S; Li X; Moll A; Friedland G; Sturm AW; Gandhi NR
    Am J Respir Crit Care Med; 2011 May; 183(10):1427-33. PubMed ID: 21297071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and Optimization of Host Immunological Bio-Signatures for a Point-of-Care Test for TB Disease.
    Mutavhatsindi H; van der Spuy GD; Malherbe ST; Sutherland JS; Geluk A; Mayanja-Kizza H; Crampin AC; Kassa D; Howe R; Mihret A; Sheehama JA; Nepolo E; Günther G; Dockrell HM; Corstjens PLAM; Stanley K; Walzl G; Chegou NN;
    Front Immunol; 2021; 12():607827. PubMed ID: 33717089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits and challenges of molecular diagnostics for childhood tuberculosis.
    Gutierrez C
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S4-S5. PubMed ID: 28043600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of tuberculosis and drug resistance: what can new tools bring us?
    Drobniewski F; Nikolayevskyy V; Balabanova Y; Bang D; Papaventsis D
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):860-70. PubMed ID: 22687497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis: lights and shadows in the current diagnostic landscape.
    Norbis L; Miotto P; Alagna R; Cirillo DM
    New Microbiol; 2013 Apr; 36(2):111-20. PubMed ID: 23686117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring tuberculosis by molecular tests on DNA isolated from smear microscopy slides.
    Rakotosamimanana N; Rabodoarivelo MS; Palomino JC; Martin A; Razanamparany VR
    Int J Infect Dis; 2017 Mar; 56():248-252. PubMed ID: 27979786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Molecular Diagnosis of Tuberculosis.
    MacLean E; Kohli M; Weber SF; Suresh A; Schumacher SG; Denkinger CM; Pai M
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32759357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical application of testing methods on acid-fast bacteria].
    Ichiyama S; Suzuki K
    Kekkaku; 2005 Feb; 80(2):95-111. PubMed ID: 15920982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy.
    Shete PB; Nalugwa T; Farr K; Ojok C; Nantale M; Howlett P; Haguma P; Ochom E; Mugabe F; Joloba M; Chaisson LH; Dowdy DW; Moore D; Davis JL; Katamba A; Cattamanchi A
    Int J Tuberc Lung Dis; 2017 Jul; 21(7):746-752. PubMed ID: 28633698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Auto-MODS assay, a novel tool for tuberculosis diagnosis for use in resource-limited settings.
    Wang L; Mohammad SH; Chaiyasirinroje B; Li Q; Rienthong S; Rienthong D; Nedsuwan S; Mahasirimongkol S; Yasui Y
    J Clin Microbiol; 2015 Jan; 53(1):172-8. PubMed ID: 25378569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the GenoType Mycobacteria Direct assay for direct detection of the Mycobacterium tuberculosis complex obtained from sputum samples.
    Kiraz N; Saglik I; Kiremitci A; Kasifoglu N; Akgun Y
    J Med Microbiol; 2010 Aug; 59(Pt 8):930-934. PubMed ID: 20448064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why being an expert - despite xpert -remains crucial for children in high TB burden settings.
    Bacha JM; Ngo K; Clowes P; Draper HR; Ntinginya EN; DiNardo A; Mangu C; Sabi I; Mtafya B; Mandalakas AM
    BMC Infect Dis; 2017 Feb; 17(1):123. PubMed ID: 28166728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of routine diagnostic work-up for tuberculosis in lung clinics in Yogyakarta, Indonesia: a cohort study.
    Saktiawati AMI; Subronto YW; Stienstra Y; Sumardi ; Supit F; van der Werf TS
    BMC Public Health; 2019 Apr; 19(1):363. PubMed ID: 30940123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.
    Nakiyingi L; Nonyane BA; Ssengooba W; Kirenga BJ; Nakanjako D; Lubega G; Byakika-Kibwika P; Joloba ML; Ellner JJ; Dorman SE; Mayanja-Kizza H; Manabe YC
    PLoS One; 2015; 10(7):e0133756. PubMed ID: 26222142
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.